Standard BioTools Inc. (LAB)
LAB has a market cap or net worth of $232.55 million. The enterprise value is $187.29 million.
The next estimated earnings date is Tuesday, November 7, 2023, after market close.
|Earnings Date||Nov 7, 2023|
LAB has 78.96 million shares outstanding. The number of shares has increased by 1.09% in one year.
|Shares Change (YoY)||+1.09%|
|Shares Change (QoQ)||-0.52%|
|Owned by Insiders (%)||2.79%|
|Owned by Institutions (%)||61.67%|
|EV / Earnings||n/a|
|EV / Sales||1.78|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 3.91
|Debt / Equity||n/a|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||-22.00%|
|Return on Capital (ROIC)||-35.70%|
|Revenue Per Employee||$201,629|
|Profits Per Employee||-$160,906|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has increased by +142.86% in the last 52 weeks. The beta is 1.47, so LAB's price volatility has been higher than the market average.
|52-Week Price Change||+142.86%|
|50-Day Moving Average||2.70|
|200-Day Moving Average||2.12|
|Relative Strength Index (RSI)||50.00|
|Average Volume (30 Days)||252,350|
Short Selling Information
The latest short interest is 2.74 million, so 3.47% of the outstanding shares have been sold short.
|Short Previous Month||2.55M|
|Short % of Shares Out||3.47%|
|Short % of Float||5.22%|
|Short Ratio (days to cover)||10.81|
In the last 12 months, LAB had revenue of $105.45 million and -$84.15 million in losses. Loss per share was -$1.06.
|Loss Per Share||-$1.06|
The company has $142.30 million in cash and $101.39 million in debt, giving a net cash position of $40.92 million or $0.52 per share.
|Cash & Cash Equivalents||142.30M|
|Net Cash Per Share||$0.52|
|Equity / Book Value||-113.39M|
|Book Value Per Share||-1.44|
In the last 12 months, operating cash flow was -$61.61 million and capital expenditures -$3.87 million, giving a free cash flow of -$65.47 million.
|Operating Cash Flow||-61.61M|
|Free Cash Flow||-65.47M|
|FCF Per Share||-$0.83|
Gross margin is 43.73%, with operating and profit margins of -79.83% and -79.80%.
Dividends & Yields
LAB does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for LAB is $4.00, which is 35.82% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||35.82%|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|